FDA Drug Recalls

Recalls / Class III

Class IIID-1678-2012

Product

Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92

Affected lot / code info
Lot numbers: KW10J511, KW10J512, KW10J513, KW10J514, KW10J515, BJ3167, BJ3172, BJ3177, BJ3179, BJ3188, BJ3182. Exp. 09/12

Why it was recalled

Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

Recalling firm

Firm
Sandoz Incorporated
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2555 W Midway Blvd, Broomfield, Colorado 80020-1632

Distribution

Quantity
41,761bottles.
Distribution pattern
Nationwide

Timeline

Recall initiated
2012-09-12
FDA classified
2012-09-19
Posted by FDA
2012-09-26
Terminated
2013-04-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1678-2012. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.